Development of ⁶⁴Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies

Sang‐Keun Woo, Joo Hyun Kang|Journal of Nuclear Medicine|2018

Cited by 66